Skip to content
LexBuild

New Animal Drugs; Change of Sponsor's Address

---
identifier: "/us/fr/E7-8322"
source: "fr"
legal_status: "authoritative_unofficial"
title: "New Animal Drugs; Change of Sponsor's Address"
title_number: 0
title_name: "Federal Register"
section_number: "E7-8322"
section_name: "New Animal Drugs; Change of Sponsor's Address"
positive_law: false
currency: "2007-05-02"
last_updated: "2007-05-02"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E7-8322"
document_type: "rule"
publication_date: "2007-05-02"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part 510"
fr_citation: "72 FR 24184"
fr_volume: 72
effective_date: "2007-05-02"
fr_action: "Final rule."
---

#  Names, addresses, and drug labeler codes of sponsors of approved applications.

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Final rule.

**SUMMARY:**

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's address for Alpharma, Inc.

**DATES:**

This rule is effective May 2, 2007.

**FOR FURTHER INFORMATION CONTACT:**

David R. Newkirk, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-6967, e-mail: *[email protected]* .

**SUPPLEMENTARY INFORMATION:**

Alpharma, Inc., One Executive Dr., Ft. Lee, NJ 07024, has informed FDA of a change of address to 440 Rte. 22, Bridgewater, NJ 08807. Accordingly, the agency is amending the regulations in 21 CFR 510.600(c) to reflect the change.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

**List of Subjects in 21 CFR Part 510**

Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements.

**21 CFR Part 510**

Therefore, under the Federal Food, Drug and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to  the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows:

**PART 510—NEW ANIMAL DRUGS**

**21 CFR Part 510**

1. The authority citation for 21 CFR part 510 continues to read as follows:

**Authority:**

21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

**21 CFR Part 510**

2. In § 510.600, in the table in paragraph (c)(1), revise the entry for “Alpharma, Inc.”; and in the table in paragraph (c)(2), revise the entry for “046573” to read as follows:

§ 510.600

(c) * * *

(1) * * *

| Firm name and address | Drug labeler code |
| --- | --- |
| *    *    *    *    * |  |
| Alpharma, Inc., 440 Rte. 22, Bridgewater, NJ 08807 | 046573 |
| *    *    *    *    * |  |

(2) * * *

| Drug labeler code | Firm name and address |
| --- | --- |
| *    *    *    *    * |  |
| 046573 | Alpharma, Inc., 440 Rte. 22, Bridgewater, NJ 08807 |
| *    *    *    *    * |  |

Dated: April 24, 2007.

Bernadette Dunham,

Deputy Director, Center for Veterinary Medicine.